Neurological Manifestations of Mycoplasma pneumoniae Infection in Hospitalized Children: A Single-Center Experience
Abstract
Objective: Mycoplasma pneumoniae is one of the major causes of upper and lower respiratory tract infection in childhood. Neurological diseases are among the most common extrapulmonary manifestations.This study aimed to share our center’s experience regarding the treatment characteristics and clinical and radiological course of patients with M. pneumoniae-related neurological symptoms in light of the available evidence.
Material and Methods: The study included in hospitalized patients with positive primary M. pneumoniae serology M. pneumoniae serology was examined in serum from the acute period and, if possible, convalescent serum (1-4 weeks after disease onset) using M. pneumoniae-specific immunoglobulin M (IgM) and IgG enzyme-linked immunoassay. A 4-fold or greater increase in IgG titer between acute and convalescent serum samples was considered diagnostic for M. pneumoniae infection. The clinical, laboratory, and imaging results and demographic data of patients with CNS involvement were evaluated.
Results: Review of the patients’ charts showed that 13 (25%) of the 52 patients with confirmed M. pneumoniae infection had neurological symptoms and findings. When evaluated together with clinical, laboratory, and imaging results, 6 patients were diagnosed with acute cerebellar ataxia, 4 patients with encephalitis, and 1 patient each with GBS, optic neuritis, and longitudinally extensive transverse myelitis.
Conclusion: Although M. pneumoniae is known as mainly a respiratory pathogen, it also causes various neurological disorders. Although all of our patients had symptoms of respiratory tract infection, it has been shown that that M. pneumoniae can also cause neurological disease without respiratory symptoms. Further studies are needed to evaluate the most appropriate methods for early diagnosis and treatment of neurological involvement, considering the long-term burden of the disease.
Keywords
References
- Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004;17:697-728.
- Christie LJ, Honarmand S, Talkington DF, Shilpa S, Gavali, Preas C, et al. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics 2007;120: 305-13.
- Ponka A. Central nervous system manifestations associated with serologically verified Mycoplasma pneumoniae infection. Scand J Infect Dis1980; 12:175–84.
- Yis U, Kurul, S H Cakmakçi H, Dirik E. Mycoplasma pneumoniae: nervous system complications in childhood and review of the literature. Eur J Pediatr 2008; 167:973–8.
- Pillai SC, Hacohen Y, Tantsis E, Prelog K, Merheb V, Kesson A, et al. Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome. Pediatrics 2015; 135:974–84.
- Meyer Sauteur PM, Huizinga R, Tio-Gillen A P, Roodbol J, Hoogen boezem T, Jacobs E, et al. Mycoplasma pneumoniae triggering the Guillain-Barré syndrome: a case-control study. Ann Neurol 2016;80:566–80.
- Al-Zaidy SA, Mac Gregor D, Mahant S, Richardson SE, Bitnun A. Neurological complications of PCR-proven M. pneumoniae infections in children: Prodromal illness duration may reflect pathogenetic mechanism. Clin Infect Dis 2015;61:1092–8.
- Thomas NH Collins JE, Robb SA, Robinson RO. Mycoplasma pneumoniae infection and neurological disease. Arch Dis Child 1993;69:573–6 .
Details
Primary Language
English
Subjects
Internal Diseases
Journal Section
Research Article
Authors
Halil Celik
*
0000-0002-2022-2909
Türkiye
Erhan Aksoy
0000-0002-7210-6715
Türkiye
Ülkühan Öztoprak
0000-0002-7309-3215
Türkiye
Meltem Akçaboy
0000-0002-0862-3961
Türkiye
Zeynep Savas Sen
0000-0003-4671-6082
Türkiye
Deniz Yüksel
0000-0001-8990-023X
Türkiye
Publication Date
September 20, 2022
Submission Date
January 4, 2022
Acceptance Date
February 23, 2022
Published in Issue
Year 2022 Volume: 16 Number: 5